V
Victoria33
Guest
by Reuters
Thursday, 23 April 2020 17:01 GMT
(Adds details on report, background)
April 23 (Reuters) - Gilead Sciences Inc’s experimental coronavirus drug failed its first randomised clinical trial, the Financial Times reported on Thursday, citing draft documents published accidentally by the World Health Organization.
Trading in the shares of the company was halted after they fell 6%.
The Chinese trial showed the antiviral remdesivir did not improve patients’ condition or reduce the pathogen’s presence in the bloodstream, the report Subscribe to read | Financial Times said.